As part of expanding and strengthening its bioscience operations, Japan-based Tosoh Corporation has acquired Lilac Medicare an in-vitro diagnostics company headquartered in Mumbai, India, reports BioSpectrum.
Established in 1997, the Lilac Group operates in the fields of two main technologies: ELISA and Chemi-luminescence and caters to the diagnostic needs of its customers in the specialties of endocrinology, cancer, tuberculosis, hepatitis, ToRCH and autoimmune diseases. It has recently entered the fields of clinical biochemistry, hematology, and electrophoresis.
By building on Lilac’s network, Tosoh hopes to increase its share in the growing Indian market by using its own immunological and diabetes diagnostic analyzers as stepping stones towards expanding its bioscience business in India.
